BIOMARIN PHARMACEUTICAL INC (BMRN) Cost of Revenue USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Biomarin Pharmaceutical Inc quarterly/annual Cost of Revenue history and growth rate from 2010 to 2024.
  • Biomarin Pharmaceutical Inc Cost of Revenue for the quarter ending March 31, 2024 was $125 M, a 7.6% decline year-over-year.
  • Biomarin Pharmaceutical Inc Cost of Revenue for the twelve months ending March 31, 2024 was $505 M, a 0.48% increase year-over-year.
  • Biomarin Pharmaceutical Inc annual Cost of Revenue for 2023 was $515 M, a 6.45% increase from 2022.
  • Biomarin Pharmaceutical Inc annual Cost of Revenue for 2022 was $484 M, a 2.8% increase from 2021.
  • Biomarin Pharmaceutical Inc annual Cost of Revenue for 2021 was $471 M, a 10.3% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $505 M $125 M -$10.3 M -7.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $515 M $127 M -$735 K -0.58% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $516 M $125 M +$8.46 M +7.27% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $507 M $128 M +$4.96 M +4.03% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $502 M $135 M +$18.5 M +15.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q4 2022 $484 M $127 M +$7.54 M +6.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $476 M $116 M +$12.8 M +12.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $463 M $123 M -$3.94 M -3.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $467 M $117 M -$3.2 M -2.66% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $471 M $120 M -$6.39 M -5.06% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $477 M $104 M -$85.3 M -45.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 $562 M $127 M +$29.1 M +29.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $533 M $120 M +$8.79 M +7.89% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $524 M $126 M +$30.2 M +31.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $494 M $189 M +$91.8 M +94.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $402 M $98 M +$20.5 M +26.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $382 M $111 M +$22.2 M +24.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $359 M $95.9 M +$20.9 M +27.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $339 M $96.9 M +$18.1 M +22.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $321 M $77.4 M -$1.58 M -2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $322 M $89.2 M +$6.85 M +8.32% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 $315 M $75 M -$976 K -1.28% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $316 M $78.9 M +$19.4 M +32.6% Jul 1, 2018 Sep 30, 2018 10-Q/A 2019-11-04
Q2 2018 $297 M $79 M +$22.7 M +40.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 $274 M $82.3 M +$32.3 M +64.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q4 2017 $242 M $76 M +$11.8 M +18.5% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $230 M $59.5 M +$8.74 M +17.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q2 2017 $221 M $56.3 M +$4.69 M +9.08% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $217 M $50 M +$6.89 M +16% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q4 2016 $210 M $64.1 M +$16.1 M +33.5% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $194 M $50.7 M +$15.8 M +45.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 $178 M $51.6 M +$13.6 M +35.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $164 M $43.1 M +$12.1 M +39.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $152 M $48 M +$9.72 M +25.4% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 $142 M $34.9 M +$4.98 M +16.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $137 M $38.1 M +$6.85 M +22% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $130 M $31 M +$8.18 M +35.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 $122 M $38.3 M +$21.1 M +122% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $101 M $29.9 M +$1.87 M +6.65% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 $99.4 M $31.2 M +$8.64 M +38.3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $90.7 M $22.8 M +$2.32 M +11.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 $88.4 M $17.3 M -$9.26 M -34.9% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $97.7 M $28.1 M +$3.44 M +14% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 $94.2 M $22.6 M -$1.01 M -4.27% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 $95.2 M $20.5 M +$3.4 M +19.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q4 2012 $91.8 M $26.5 M +$5.01 M +23.3% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 $86.8 M $24.6 M +$2.17 M +9.69% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-28
Q2 2012 $84.6 M $23.6 M +$4.31 M +22.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-29
Q1 2012 $80.3 M $17.1 M -$3.69 M -17.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-29
Q4 2011 $84 M $21.5 M +$1.05 M +5.13% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-26
Q3 2011 $83 M $22.4 M +$4.44 M +24.7% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-29
Q2 2011 $78.5 M $19.3 M +$4.86 M +33.8% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-02
Q1 2011 $73.7 M $20.8 M +$3.38 M +19.4% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-30
Q4 2010 $70.3 M $20.5 M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-26
Q3 2010 $18 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 $14.4 M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-01
Q1 2010 $17.4 M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.